REFERENCES
- Pepys MB. Amyloidosis. Ann RevMed 2006;57(1):223–241.
- Buxbaum JN. The systemic amyloidoses. CurrOpinRheumatol 2004;16(1):67–75.
- Picken MM. Amyloidosis—Where Are we now and where are we heading? ArchPatholLab Med 2010;134(4):545–551.
- Murdoch IE, Sullivan TJ, Moseley I, Hawkins PN, Pepys MB, Tan SY, et al. Primary localised amyloidosis of the orbit. Br JOphthalmol 1996;80(12):1083–1086.
- Holmström GE, Nyman KG. Primary orbital amyloidosis localised to an extraocular muscle. Br JOphthalmol 1987;71(1):32–33.
- Taban M, Piva A, See RF, Sadun AA, Quiros PA. Review: Orbital Amyloidosis. OphthalPlastReconstructSurg2004;20(2):162–165.
- Khaira M, Mutamba A, Meligonis G, Rose GE, Plowman PN, O’Donnell H. The use of radiotherapy for the treatment of localized orbital amyloidosis. Orbit2008;27(6):432–437.
- Leibovitch I, Selva D, Goldberg RA, Sullivan TJ, Saeed P, Davis G, et al. Periocular and orbital amyloidosis: clinical characteristics, management, and outcome. Ophthalmology 2006;113(9):1657–1664.
- Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S-I, et al. A primer of amyloid nomenclature. Amyloid 2007;14(3):179–183.
- Fraunfelder FW. Liquid Nitrogen Cryotherapy for Conjunctival Amyloidosis. Arch Ophthalmol 2009;127(5):645–648.
- Demirci H, Shields CL, Eagle RC, Shields JA. Conjunctival Amyloidosis: Report of Six Cases and Review of the Literature. SurvOphthalmol 2006;51(4):419–433.
- Gean-Marton AD, Kirsch CF, Vezina LG, Weber AL. Focal amyloidosis of the head and neck: evaluation with CT and MR imaging. Radiology 1991;181(2):521–525.
- National Amyloidosis Centre [Internet]. [cited 2012 Jan 28]; Available from: http://www.ucl.ac.uk/medicine/amyloidosis/nac.
- Knowles DM 2nd, Jakobiec FA, Rosen M, Howard G. Amyloidosis of the orbit and adnexae. SurvOphthalmol 1975;19(6):367–384.
- Hill VE, Brownstein S, Jordan DR. Ptosis secondary to amyloidosis of the tarsal conjunctiva and tarsus. Am JOphthalmol 1997;123(6):852–854.
- Shields JA, Eagle RC, Shields CL, Green M, Singh AD. Systemic amyloidosis presenting as a mass of the conjunctival semilunar fold. Am J Ophthalmol 2000;130(4):523–525.
- Conlon MR, Chapman WB, Burt WL, Larocque BJ, Hearn SA. Primary localized amyloidosis of the lacrimal glands. Ophthalmology 1991;98(10):1556–1559.
- Cheng JYC, Fong KS, Cheah ES, Choo CT. Lacrimal gland amyloidosis. Ophthal PlastReconstrSurg 2006;22(4):306–308.
- Massry GG, Harrison W, Hornblass A. Clinical and computed tomographic characteristics of amyloid tumor of the lacrimal gland. Ophthalmology 1996;103(8):1233–1236.
- Prabhakaran V, Babu K, Mahadevan A, Murthy S. Amyloidosis of lacrimal gland. Ind JOphthalmol 2009;57:461.
- Rodrigues G, Sanghvi V, Lala M. Conjunctival amyloidosis of both eyelids. Ind J Ophthalmol 2001;49(2):116–117.
- Hubbard A, Brown A, Bonshek R, Leatherbarrow B. Surgical management of primary localised conjunctival amyloidosis causing ptosis. Br J Ophthalmol 1995;79(7):707.
- Dinakaran S, Singh AD, Rennie IG. Orbital amyloidosis presenting as ptosis. Eye 2004;19(1):110–112.
- O’Donnell B, Wuebbolt G, Collin R. Amyloidosis of the conjunctiva. Aust N Z J Ophthalmol 1995;23(3):207–212.
- Dithmar S, Linke RP, Kolling G, Völcker HE, Helmke B. Ptosis from localized A-lambda-amyloid deposits in the levator palpebrae muscle. Ophthalmology 2004;111(5):1043–1047.
- Liesegang TJ. Amyloid infiltration of the levator palpebrae superioris muscle: case report. Ann Ophthalmol 1983;15(7):610–613.
- Savino PJ, Schatz NJ, Rodrigues MM. Orbital amyloidosis. Can JOphthalmol1976;11(3):252–255.
- Purcell JJ Jr, Birkenkamp R, Tsai CC, Riner RN. Conjunctival involvement in primary systemic nonfamilial amyloidosis. Am JOphthalmol1983;95(6):845–847.
- Marsh WM, Streeten BW, Hoepner JA, Zhang W, Davey FR. Localized conjunctival amyloidosis associated with extranodal lymphoma. Ophthalmology 1987;94(1):61–64.
- Gertz MA, Buadi FK, Hayman SR. Treatment of immunoglobulin light chain (primary or AL) amyloidosis. Oncology (Williston Park, NY). 2011;25(7):620–626.
- Michael M, Kastritis E, Delimpassi S, Michalis E, Repoussis P, Kyrtsonis M-C, et al. Clinical characteristics and outcome of primary systemic light-chain amyloidosis in Greece. Clin Lymphoma Myeloma Leuk 2010;10(1):56–61.
- Onur MR, Yalnız M, Poyraz AK, Ozercan IH, Ozkan Y. Pancreatic islet cell amyloidosis manifesting as a large pancreas. Kor J Radiol 2012;13(1):94–97.
- Tomita T. Amyloidosis of pancreatic islets in primary amyloidosis (AL type). PatholInt2005;55(4):223–227.
- Kuroda T, Sato H, Hasegawa H, Wada Y, Murakami S, Saeki T, et al. Fatal acute pancreatitis associated with reactive AA amyloidosis in rheumatoid arthritis with end-stage renal disease: a report of three cases. Intern Med 2011;50(7):739–744.
- Merlini G, Seldin DC, Gertz MA. Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol 2011;29(14):1924–1933.
- Adam Z, Pour L, Krejcí M, Zahradová L, Krivanová A, Mardová J, et al. [Treatment of AL-amyloidosis—Results from one clinic and review of published experience with new agents (bortezomib, thalidomide and lenalidomide) in AL-amyloidosis]. VnitrLek 2010;56(3):190–209.
- Cohen AD, Comenzo RL. Systemic light-chain amyloidosis: advances in diagnosis, prognosis, and therapy. Hematol Am SocHematolEducProg 2010:287–294.
- Banerjee S, Bogman J, Reuser TTQ. Amyloid deposition in the extraocular muscles. Orbit 1999;18(2):105–106.
- Patrinely JR, Koch DD. Surgical management of advanced ocular adnexal amyloidosis. ArchOphthalmol 1992;110(6):882–885.